[Managements for XXXX ].

@entity1 @entity3883 @entity788 @entity1087 @entity548 @entity5 @entity1066 @entity341 @entity344 @entity1578 @entity255 @entity356 @entity3 @entity14 @entity3638 @entity1125
@entity1087 is a yellowish pigmentation of skin and mucous membranes caused by @entity3638 , which itself has various causes. @entity1087 related to @entity5 is classified as @entity3883 . This disease proceeds from biliary tract obstruction and @entity1578 by progression of @entity5 , including @entity3 from other @entity5 . @entity1125 , @entity788 , or lymph nodes @entity3 from other sites of @entity5 are mainly responsible for the obstruction of the bile duct. In @entity1 with @entity3883 , biliary drainage is often required in order to give treatments such as chemotherapy. In @entity1 with biliary drainage, various complications arise, such as @entity255 due to obstruction ofa biliary stent, and @entity548 from the @entity1066 due to a dislodged stent to the duodenum. It is crucial to manage those complications as @entity341 . @entity1087 of @entity1578 due to hepatic @entity3 is often observed in @entity1 with @entity344 such as @entity356 or @entity14 . Although chemotherapy is the usual application for those patients, useful anti- @entity5 agents are limited. It is crucial to diagnose and decide the best treatments as soon as possible for @entity1 with very advanced hepatic @entity3 .
